Home > Boards > US OTC > Food - Processing and Agriculture >

Plandai Biotechnology, Inc. (PLPL)

PLPL RSS Feed
Add PLPL Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator Aston Martin, UNDAUNTED
Search This Board:
Last Post: 7/30/2014 6:57:03 AM - Followers: 190 - Board type: Free - Posts Today: 3


www.plandaibiotech.com

Information Update May 20, 2014

Movie by Plandai:

http://vimeo.com/95723836


 

Plandaí and Cannabis – What is Our Role?

When Plandaí first announced its intention to produce a Phytofare™ Cannabinoid Extract, we were inundated with phone calls and emails—the majority of which wanted to know when and where they could buy some.  Since that time, we’ve read different articles and blog posts speculating that Plandaí is growing marijuana on its South Africa plantation and importing its extract to Washington under the Diego Pellicer brand name. 

With all of this misinformation out there, we felt it appropriate to “set the record straight” with respect to Plandaí and its involvement in the marijuana industry.

First, Plandaí is NOT presently producing any type of cannabis extract nor are we farming cannabis in South Africa, Washington or anywhere else.  There are many reasons for this, but primarily we recognize that cannabis cultivation and extract production is illegal—everywhere—unless you have special permission from the government.  Notwithstanding recent legislation in Washington and Colorado, growing, processing, possessing and selling marijuana in any form is still illegal on the federal level.  Plandaí has no intention of crossing this line.  Internationally, growing marijuana is illegal, especially in South Africa and other countries where we operate.

Initially, our attorneys believed we could set up a lab and begin testing in Washington.  We set this process in motion by designing the equipment and reaching out to local scientists and researchers.  We then determined that, if followed through upon, our activities could potentially violate federal laws and we immediately halted any efforts to produce an extract in the US.

With that being said, Plandaí believes that cannabis shows great medical potential.  Unfortunately, very little testing has been done in a true, double-blind, controlled human clinical environment.  Much of what we know is either anecdotal or backed by small lab-scale studies.  We have developed the science that will allow us to produce a highly bioavailable cannabinoid complex.  This new product should enable us to deliver a clinical dose of cannabinoids directly to human tissue and, theoretically, even cross the blood-brain barrier, enabling us to treat neuron disorders.  Without testing, however, this is all theoretical.   

Plandaí is actively working with several government agencies in hopes of being granted permission to commence testing our cannabinoid product.  Once this permission is received, it will take us about ninety days to set up an extraction lab and produce the first extract.  This extract will then be tested for purity and undergo a full chemical profile.  Only then will be begin animal studies to determine what, if any, medicinal benefits are present.  Favorable lab studies will eventually lead to human clinical trials but, again, only with proper government sanctioning. 

We believe that favorable clinical trials will eventually pave the way for government acceptance.  Especially for products like Plandaí’s which will have no psychoactive effects.  Once we reach that point, we will have several decisions to make: Do we produce an extract locally? Do we license the technology to a third party? Do we farm our own product or purchase from a local grower?  We cannot begin to answer these questions until we first have clinical results and then take account of the legal landscape at such future date.

The takeaway for our investors is that Plandaí remains committed to conducting ongoing research with a variety of different plants including cannabis and that this research will go forward as fast as the legal climate permits.  Until such time, we remain committed to obeying the laws—federal, state, and international—while we continue to champion for changes to those laws and establish industry standards.  We have a fiduciary responsibility to our shareholders to ensure that our company is built on a solid foundation of science, ethics, frugality, and adherence to the laws of the land.

We will continue to keep our shareholders aware of any changes to legislation and any government-approved dispensations we obtain.

 

 









Quarterly report December 2013
http://www.sec.gov/Archives/edgar/data/1317880/000126246313000072/plpl10q.htm


Security Details


Plandai Biotechnology, Inc. is a fully reporting SEC company, publicly traded on the OTC Market under the symbol, "PLPL". As such, Business, operational and financial information on PLPL is fully transparent and available to public view.  


                                                                                                            A/S :        500 million confirmed / State of Nevada

                                                                                                            O/S :       Approx. 125.000.000
                                                                                                                                                                                                         
                                                                                                                                                                                  Free Float:        unknown
 

Incorporated in: NV,USA

Year of Inc.:  2012


Transfer Agent

Signature Stock Transfer, Inc.

Transfer Agent, 2632 Coachlight Ct., Plano, TX, 75093

972-612-4120

SignatureStock@aol.com



 

Plandai Biotechnology Names Diego Pellicer Co-Founder and CannabisPioneer Jamen Shively as Vice President of Global Marketing

Recently Appointed Board Member Joins Management Team to Oversee Branding and Product Strategy

NEW YORK, NY, Feb 20, 2014 (Menafn - Marketwired via COMTEX) --Plandai Biotechnology, Inc. (otcqb:PLPL), a producer of highlybioavailable plant extracts for industries including health,wellness, nutraceutical, and pharmaceutical, announced today thatJamen Shively, a leading voice in the burgeoning marijuana industryand recently appointed Board Member of Plandai, has been named asVice President of Global Marketing.

As VP-Global Marketing, the company released, Mr. Shively will beresponsible for building brand awareness and marketing strategy forall of Plandai's operations including the Diego Pellicer(R) medicalcannabis line as well as the Phytofare(TM) botanical extracts such asthe Green Tea Catechin Complex and the Limonoid Glycoside Complex.

Roger Duffield, Chief Executive Officer of Plandai, commented on Mr.Shively's new position within the Company, "We're excited to bringJamen fully into the Plandai fold. He did a brilliant job buildingthe Diego Pellicer brand, and we're confident that he will build onthis experience as we launch the first of our products in the comingweeks. Our goal is to become the leading name in highly bioavailablebotanical extracts for both nutraceutical and pharmaceuticalapplications. Jamen has the vision and expertise to help further ustowards that end."

Mr. Shively stated, "I could not be more pleased to come aboardPlandai, first as a Director and now as a full-time member of themanagement team. Plandai is uniquely positioned in that it has noreal direct competition -- no one else in the market is selling highbioavailability plant extracts. Consumers are starting to demand morefrom their vitamins and supplements and asking to what extent are thebillions of dollars being spent on such products actually increasinghealth and wellness. My role with Plandai, as I see it, is to educatethe consumer that they need to demand more from their supplementswhile also telling the Plandai story. We have a unique opportunitywith Plandai's technology to fundamentally change how we addresswellness, health and prevention through natural, botanicalsolutions."

He added, "I am also extremely excited about the application ofPlandai's technologies to cannabis, which I believe willrevolutionize the application of cannabis to preventive andtherapeutic health, under the Diego Pellicer brand. This is theopportunity of a lifetime for me and for my colleagues at Plandai tochange the world by improving the health and wellness of mankindthrough 100% natural plant extracts. We are unlocking the potentialof nature's plant nutrients for humans and animals alike."

Jamen Shively, age 45, has a background in engineering and marketing,with specialties in artificial intelligence, the modeling andoptimization of complex networks, and the creation and positioning ofnew categories of products and services. Jamen co-founded DiegoPellicer Inc. in 2012 and built the brand from zero to the #1 mostrecognized brand of cannabis in the world in less than one year.Prior to founding Diego Pellicer, Jamen was a Corporate StategyManager for Microsoft from 2003 to 2009, where he focused on thecreation and development of new categories of software products andonline services. Preceding his Microsoft career he headed ShivelyInternational Inc., which built and operated both cybercafes andeducational computer centers in Mexico. Just prior to founding DiegoPellicer Inc., Jamen founded and headed the online marketplace forthe specialty food industry, Findood, winning first place in theNorthwest Entrepreneur Network's First Look Forum Competition for thetop new startup in 2010. Jamen completed his undergraduate work atU.C. Berkeley in Civil Engineering, and did graduate work at M.I.T.and U.C. Berkeley in Civil Engineering and Materials Science. He is aFellow of the National Science Foundation.

Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing

PLPL, BIOGY

NEW YORK, NY- via eTeligis (Feb 20, 2014) -  Planda Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Planda, has been named as Vice President of Global Marketing.

 

As VP-Global Marketing, the company released, Mr. Shively will be responsible for building brand awareness and marketing strategy for all of Planda's operations including the Diego Pellicer medical cannabis line as well as the Phytofare botanical extracts such as the Green Tea Catechin Complex and the Limonoid Glycoside Complex.

 

Roger Duffield, Chief Executive Officer of Planda, commented on Mr. Shively's new position within the Company, "We're excited to bring Jamen fully into the Planda fold. He did a brilliant job building the Diego Pellicer brand, and we're confident that he will build on this experience as we launch the first of our products in the coming weeks. Our goal is to become the leading name in highly bioavailable botanical extracts for both nutraceutical and pharmaceutical applications. Jamen has the vision and expertise to help further us towards that end." 

 

Mr. Shively stated, "I could not be more pleased to come aboard Planda, first as a Director and now as a full-time member of the management team. Planda is uniquely positioned in that it has no real direct competition -- no one else in the market is selling high bioavailability plant extracts. Consumers are starting to demand more from their vitamins and supplements and asking to what extent are the billions of dollars being spent on such products actually increasing health and wellness. My role with Planda, as I see it, is to educate the consumer that they need to demand more from their supplements while also telling the Planda story. We have a unique opportunity with Planda's technology to fundamentally change how we address wellness, health and prevention through natural, botanical solutions." 

 

He added, "I am also extremely excited about the application of Planda's technologies to cannabis, which I believe will revolutionize the application of cannabis to preventive and therapeutic health, under the Diego Pellicer brand. This is the opportunity of a lifetime for me and for my colleagues at Plandai to change the world by improving the health and wellness of mankind through 100% natural plant extracts. We are unlocking the potential of nature's plant nutrients for humans and animals alike."

 

Jamen Shively, age 45, has a background in engineering and marketing, with specialties in artificial intelligence, the modeling and optimization of complex networks, and the creation and positioning of new categories of products and services. Jamen co-founded Diego Pellicer Inc. in 2012 and built the brand from zero to the #1 most recognized brand of cannabis in the world in less than one year. Prior to founding Diego Pellicer, Jamen was a Corporate Stategy Manager for Microsoft from 2003 to 2009, where he focused on the creation and development of new categories of software products and online services. Preceding his Microsoft career he headed Shively International Inc., which built and operated both cybercafs and educational computer centers in Mexico. Just prior to founding Diego Pellicer Inc., Jamen founded and headed the online marketplace for the specialty food industry, Findood, winning first place in the Northwest Entrepreneur Network's First Look Forum Competition for the top new startup in 2010. Jamen completed his undergraduate work at U.C. Berkeley in Civil Engineering, and did graduate work at M.I.T. and U.C. Berkeley in Civil Engineering and Materials Science. He is a Fellow of the National Science Foundation.


Read more at http://www.stockhouse.com/news/press-releases/2014/02/20/plandai-biotechnology-names-diego-pellicer-co-founder-and-cannabis-pioneer#bRlEkKORllERl0oV.99

February 14, 2014 09:00 ET

Marijuana Entrepreneur Jamen Shively Goes Public With Plandai Biotechnology, Inc.

NEW YORK, NY--(Marketwired - Feb 14, 2014) - If Plandaí Biotechnology (OTCQB: PLPL) investors liked the idea of Diego Pellicer co-founder Jamen Shively working with the company from the outside, then they'll love the idea that he's now on the inside of this public biotech. Jamen Shively, a former Microsoft executive turned marijuana entrepreneur, has gone public being named to the Board of Directors at Plandaí. 

His experience at Microsoft alone makes this a great business move, but the media's attraction to Shively's confident approach to capturing 40 percent of the worldwide marijuana market makes his addition inside any public company a really big deal. Hopefully Plandaí is prepared for the media frenzy that is likely to occur when the national press that showed up en masse to his 2013 press conference, learns of Shively's appointment to the Board.

Plandaí recently completed a deal with Diego Pellicer, Inc. that allows it to market its Phytofare™ Cannabis extracts under the Diego Pellicer Gold brand, so it makes a lot of sense to Roger Duffield, CEO of Plandaí, to have Jamen Shively spearheading that branding process from inside the company. "Jamen brings a wealth of experience in both engineering and branding to Plandaí not to mention his bold leadership in the Cannabis field." 

It's that bold leadership that makes Shively so attractive to the media and his "first to mind" approach will keep him in the headlines as the marijuana debate unfolds. With headlines like: "Ex-Microsoft Employee Is Going Big In The Marijuana Business," "Jamen Shively, Former Microsoft Manager, To Launch 'Premium Marijuana' Business In Washington," and "Ex-Microsoftie Jamen Shively Is Building A Marijuana Empire," Shively is clearly proving his point. 

The man some are calling the "Bill Gates of Cannabis" has the attention of the media and can likely command a microphone or writer just about any time he wants. For Plandaí and its investors, Shively's not a bad guy to have around your public company, especially in a burgeoning market.

And, this is exactly what Duffield understands as his company looks to move into production and sales of its Cannabis extracts. The CEO said, "As a member of Plandaí's Board, Jamen will be instrumental in helping shape our corporate policy and direction as we move from being a research company into production and sales in the coming months."


Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing

PLPL, BIOGY

NEW YORK, NY- via eTeligis (Feb 20, 2014) -  Planda Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Planda, has been named as Vice President of Global Marketing.

 

As VP-Global Marketing, the company released, Mr. Shively will be responsible for building brand awareness and marketing strategy for all of Planda's operations including the Diego Pellicer medical cannabis line as well as the Phytofare botanical extracts such as the Green Tea Catechin Complex and the Limonoid Glycoside Complex.

 

Roger Duffield, Chief Executive Officer of Planda, commented on Mr. Shively's new position within the Company, "We're excited to bring Jamen fully into the Planda fold. He did a brilliant job building the Diego Pellicer brand, and we're confident that he will build on this experience as we launch the first of our products in the coming weeks. Our goal is to become the leading name in highly bioavailable botanical extracts for both nutraceutical and pharmaceutical applications. Jamen has the vision and expertise to help further us towards that end." 

 

Mr. Shively stated, "I could not be more pleased to come aboard Planda, first as a Director and now as a full-time member of the management team. Planda is uniquely positioned in that it has no real direct competition -- no one else in the market is selling high bioavailability plant extracts. Consumers are starting to demand more from their vitamins and supplements and asking to what extent are the billions of dollars being spent on such products actually increasing health and wellness. My role with Planda, as I see it, is to educate the consumer that they need to demand more from their supplements while also telling the Planda story. We have a unique opportunity with Planda's technology to fundamentally change how we address wellness, health and prevention through natural, botanical solutions." 

 

He added, "I am also extremely excited about the application of Planda's technologies to cannabis, which I believe will revolutionize the application of cannabis to preventive and therapeutic health, under the Diego Pellicer brand. This is the opportunity of a lifetime for me and for my colleagues at Plandai to change the world by improving the health and wellness of mankind through 100% natural plant extracts. We are unlocking the potential of nature's plant nutrients for humans and animals alike."

 

Jamen Shively, age 45, has a background in engineering and marketing, with specialties in artificial intelligence, the modeling and optimization of complex networks, and the creation and positioning of new categories of products and services. Jamen co-founded Diego Pellicer Inc. in 2012 and built the brand from zero to the #1 most recognized brand of cannabis in the world in less than one year. Prior to founding Diego Pellicer, Jamen was a Corporate Stategy Manager for Microsoft from 2003 to 2009, where he focused on the creation and development of new categories of software products and online services. Preceding his Microsoft career he headed Shively International Inc., which built and operated both cybercafs and educational computer centers in Mexico. Just prior to founding Diego Pellicer Inc., Jamen founded and headed the online marketplace for the specialty food industry, Findood, winning first place in the Northwest Entrepreneur Network's First Look Forum Competition for the top new startup in 2010. Jamen completed his undergraduate work at U.C. Berkeley in Civil Engineering, and did graduate work at M.I.T. and U.C. Berkeley in Civil Engineering and Materials Science. He is a Fellow of the National Science Foundation.


Read more at http://www.stockhouse.com/news/press-releases/2014/02/20/plandai-biotechnology-names-diego-pellicer-co-founder-and-cannabis-pioneer#bRlEkKORllERl0oV.99

 

Plandai Biotechnology Names Diego Pellicer Co-Founder and Cannabis Pioneer Jamen Shively as Vice President of Global Marketing

PLPL, BIOGY

NEW YORK, NY- via eTeligis (Feb 20, 2014) -  Planda Biotechnology, Inc. (OTCQB: PLPL), a producer of highly bioavailable plant extracts for industries including health, wellness, nutraceutical, and pharmaceutical, announced today that Jamen Shively, a leading voice in the burgeoning marijuana industry and recently appointed Board Member of Planda, has been named as Vice President of Global Marketing.

 

As VP-Global Marketing, the company released, Mr. Shively will be responsible for building brand awareness and marketing strategy for all of Planda's operations including the Diego Pellicer medical cannabis line as well as the Phytofare botanical extracts such as the Green Tea Catechin Complex and the Limonoid Glycoside Complex.

 

Roger Duffield, Chief Executive Officer of Planda, commented on Mr. Shively's new position within the Company, "We're excited to bring Jamen fully into the Planda fold. He did a brilliant job building the Diego Pellicer brand, and we're confident that he will build on this experience as we launch the first of our products in the coming weeks. Our goal is to become the leading name in highly bioavailable botanical extracts for both nutraceutical and pharmaceutical applications. Jamen has the vision and expertise to help further us towards that end." 

 

Mr. Shively stated, "I could not be more pleased to come aboard Planda, first as a Director and now as a full-time member of the management team. Planda is uniquely positioned in that it has no real direct competition -- no one else in the market is selling high bioavailability plant extracts. Consumers are starting to demand more from their vitamins and supplements and asking to what extent are the billions of dollars being spent on such products actually increasing health and wellness. My role with Planda, as I see it, is to educate the consumer that they need to demand more from their supplements while also telling the Planda story. We have a unique opportunity with Planda's technology to fundamentally change how we address wellness, health and prevention through natural, botanical solutions." 

 

He added, "I am also extremely excited about the application of Planda's technologies to cannabis, which I believe will revolutionize the application of cannabis to preventive and therapeutic health, under the Diego Pellicer brand. This is the opportunity of a lifetime for me and for my colleagues at Plandai to change the world by improving the health and wellness of mankind through 100% natural plant extracts. We are unlocking the potential of nature's plant nutrients for humans and animals alike."

 

Jamen Shively, age 45, has a background in engineering and marketing, with specialties in artificial intelligence, the modeling and optimization of complex networks, and the creation and positioning of new categories of products and services. Jamen co-founded Diego Pellicer Inc. in 2012 and built the brand from zero to the #1 most recognized brand of cannabis in the world in less than one year. Prior to founding Diego Pellicer, Jamen was a Corporate Stategy Manager for Microsoft from 2003 to 2009, where he focused on the creation and development of new categories of software products and online services. Preceding his Microsoft career he headed Shively International Inc., which built and operated both cybercafs and educational computer centers in Mexico. Just prior to founding Diego Pellicer Inc., Jamen founded and headed the online marketplace for the specialty food industry, Findood, winning first place in the Northwest Entrepreneur Network's First Look Forum Competition for the top new startup in 2010. Jamen completed his undergraduate work at U.C. Berkeley in Civil Engineering, and did graduate work at M.I.T. and U.C. Berkeley in Civil Engineering and Materials Science. He is a Fellow of the National Science Foundation.


Read more at http://www.stockhouse.com/news/press-releases/2014/02/20/plandai-biotechnology-names-diego-pellicer-co-founder-and-cannabis-pioneer#bRlEkKORllERl0oV.99

For press releases please visit: www.plandaibiotech.com/press-release.html

_______________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 

Management Team
Roger Duffield
President, Chief Executive officer and member of the Board of Directors

Callum Baylis-Duffield
Vice-President and Global Director: Marketing
Sales

David Rzepnicki
Chief Financial Officer and member of the Board of Directors

Tim Matula
Investor Relations and member of the Board of Directors

Contact:
Corporate Headquarters
Address: 2226 Eastlake Ave E, #156
Seattle, Washington, 98102, USA
Phone: (425) 466-0212
Website:
http://www.plandaibiotech.com
Email: Info@plandaibiotech.com



LIST OF RESEARCHES, COVERAGE, ETC. :


http://www.cpreports.com/2013/05/22/ray-dirks-research-plandai-biotechnology-plpl-may-23-2013-by-ray-dirks/
............................... 
" Ray Dirks Research is projecting price targets for Plandaí Biotechnology, Inc. of $1.00 for the Short Term (6 to 9 Months) and $3.00 for the Long Term (1 to 3 Years)."


http://www.goldmanresearch.com/Search.html?ordering=&searchphrase=all&searchword=plandai
................................  "As commercialization and further testing occurs, the shares should approach the $2.00 level in 2013."

http://www.otcjournal.com
..................".....I've always had a 2013 price target on PLPL of $1.00. Based on the last 10 days, it looks like I'll be right on this one. I hope you own PLPL."

http://www.stockmarketmediagroup.com/wp-content/uploads/2013/04/Plandai-Biotechnology-Inc.-PLPL-Research-Report.pdf



                                                                                                                                                    PLANDAI BIOTECHNOLOGY at Africa                                                  

          
 

PostSubject
#11220  Sticky Note PLPL - MUST WATCH: Aston Martin 05/20/14 09:18:30 AM
#11634   wish they had made that conection in the article---------nada-------------tmonke tmonkey 07/30/14 05:49:56 AM
#11633   Read posts properly before you comment. That is Aston Martin 07/30/14 03:47:32 AM
#11632   Plandai tweeted they expect to ship product in brandao 07/29/14 08:44:48 PM
#11631   Bold statement now are you insinuating Jamen is Blazing Stock 07/29/14 05:57:57 PM
#11630   I do not underestimate the rule of Shively Aston Martin 07/29/14 05:23:05 PM
#11629   Plandai is licensed to make diego products. Blazing Stock 07/29/14 03:42:53 PM
#11628   agree------and we need to see promised revenues soon--and tmonkey 07/29/14 02:55:24 PM
#11627   PLPL really shouldn't be considered an mj play tomatotom 07/29/14 02:51:34 PM
#11626   unfortunate they dont mention plandai anywhere!!!--------tmon´key tmonkey 07/29/14 02:22:20 PM
#11625   Always good.. Rdhoughton 07/29/14 01:48:23 PM
#11624   JAMEN : http://www.adweek.com/news/advertising-branding/who-will-become-starbuc Blazing Stock 07/29/14 01:47:45 PM
#11623   Good to see our VP is in the Blazing Stock 07/29/14 12:10:17 PM
#11622   Whoever nite was that cut me off at kthanks24 07/29/14 09:51:14 AM
#11621   Beside of many progress since 2012, PLPL management Aston Martin 07/28/14 01:23:44 PM
#11620   lol how about that 131k bearish candle? kthanks24 07/28/14 11:57:59 AM
#11619   I agree with this..Though hopeful for any attention. Rdhoughton 07/28/14 11:45:54 AM
#11618   summer hole on board and chart. I worry Aston Martin 07/28/14 11:39:54 AM
#11617   I do not wonder! Typical penny companies: Wonderful Aston Martin 07/24/14 06:40:23 PM
#11616   $PLPL Good point Brando...Well it's the start captainscotty 07/24/14 05:49:57 PM
#11615   .40s held pretty well but now into .30s-----absoultly tmonkey 07/24/14 11:01:09 AM
#11614   Can these people please just post something about brandao 07/23/14 09:28:22 PM
#11613   I'm not expecting much in revenueland but I tradetrak 07/21/14 03:04:09 PM
#11612   a bit strange: Whenever pennystocks have to release Aston Martin 07/21/14 10:11:34 AM
#11611   didnt imply it was my cup of tea tmonkey 07/19/14 12:22:59 PM
#11610   ....friday chart as usual. Obvioulsy some tiny trader Aston Martin 07/18/14 01:28:12 PM
#11609   unfortunately this is not the kind of game Aston Martin 07/18/14 10:48:50 AM
#11608   you guys must both be atending opening day tmonkey 07/18/14 05:07:00 AM
#11607   $PLPL LOL...:-} Looks like we will have a captainscotty 07/17/14 07:20:18 PM
#11606   .23 is too early, I prefer .22 Aston Martin 07/17/14 07:12:16 PM
#11605   $PLPL Thanks STOCKman.PLPL is on the right track...Still captainscotty 07/17/14 06:34:46 PM
#11604   $PLPL recent news/filings stocktrademan 07/17/14 10:09:02 AM
#11603   Pleasing closing price. Promising as usually in summer Aston Martin 07/16/14 07:14:01 PM
#11602   held .40 on a real red day---------doubt that tmonkey 07/16/14 03:19:21 AM
#11601   Losing? Why? Just because I doubt PLPL is Aston Martin 07/15/14 08:33:43 PM
#11600   Lol sorry if you're losing Aston.. I sold Rdhoughton 07/15/14 01:56:49 PM
#11599   did you forget? This is 'going to da Aston Martin 07/15/14 12:53:00 PM
#11598   all red today----surprised we havent fallen under .40----my tmonkey 07/15/14 12:39:06 PM
#11597   pennystock companies are not interested in shareholder, they Aston Martin 07/15/14 06:01:07 AM
#11596   and lower we go---------------when they finally report earnings tmonkey 07/15/14 03:30:17 AM
#11595   Nothing going on here untill revs start from brandao 07/14/14 11:47:19 AM
#11594   PLPL starts today how it usually end on fridays Aston Martin 07/14/14 10:16:49 AM
#11593   Morning PLPL, Lets hear about Washington State! jjh573 07/14/14 09:18:47 AM
#11592   with this opinion you should avoid to speculate Aston Martin 07/14/14 05:41:55 AM
#11591   That responsibilty lies with the CEO pertaining to midnightsal 07/13/14 09:48:41 PM
#11590   In this case I can't agree, as penny Aston Martin 07/13/14 01:13:55 PM
#11589   I sold all my PLPL stock friday, CEO midnightsal 07/13/14 11:11:33 AM
#11588   I am amazed about all those enormous experienced Aston Martin 07/12/14 04:23:45 AM
#11587   Lol shutup . PLPL will move when you Rdhoughton 07/12/14 02:29:04 AM
#11586   However, finally a tiny bit positive friday Aston Martin 07/11/14 04:07:47 PM
#11585   Sorry, I am not whining at all - Aston Martin 07/11/14 04:05:25 PM
PostSubject